OverviewChartNewsTraderScreen

UniCredit Call 0.75 VODI 19.06.20.../  DE000HD1H4Y7  /

Frankfurt Zert./HVB
2024-05-29  4:46:05 PM Chg.-0.002 Bid5:27:19 PM Ask5:27:19 PM Underlying Strike price Expiration date Option type
0.008EUR -20.00% -
Bid Size: -		 -
Ask Size: -		 VODAFONE GROUP PLC 0.75 - 2024-06-19 Call
TeleTrader 04-04 UK's CMA orders phase 2 probe into Vodafone, Three deal
TeleTrader 03-22 Vodafone, Three may face in-depth probe by CMA
TeleTrader 03-15 Swisscom to acquire Vodafone Italy for €8 billion
TeleTrader 02-28 Europe opens mostly lower with economy in focus
TeleTrader 02-28 Vodafone confirms talks on selling Italian subsidiary for €8B
TeleTrader 02-13 Samsung, Princeton Univ. to develop 6G network
TeleTrader 01-26 UK to investigate Vodafone, Three UK merger
TeleTrader 01-16 Vodafone, Microsoft forge 10-year partnership for AI, cloud services
TeleTrader 01-11 2023: A job loss tsunami in the tech industry
TeleTrader 2023-12-18 Vodafone jumps 6% on Iliad Group merger bid
TeleTrader 2023-12-08 Main UK mobile firms face £3.3B class action suit
TeleTrader 2023-10-02 Europe's telecom firms likely to ask for higher fees for Big Tech
TeleTrader 2023-09-22 Zegona confirms talks to buy Vodafone Spain
TeleTrader 2023-06-26 Europe closes mixed on downbeat data
TeleTrader 2023-06-09 Europe opens mixed ahead of next week's data
TeleTrader 2023-06-08 Europe closes mostly higher after GDP report
TeleTrader 2023-05-16 Vodafone tumbles over 7% after job cuts news
TeleTrader 2023-05-15 Vodafone reportedly preparing £1B sale of IoT unit stake
TeleTrader 2023-04-27 Vodafone names Margherita Della Valle new CEO
Newsfile Corp 2023-04-13 Valorem Announces Appointment of Sir Samuel Jonah as Senior Advisor
TeleTrader 2022-12-05 Vodafone CEO to resign at the end of December
TeleTrader 2022-10-03 Vodafone, Three UK near merger deal - report
GlobeNewswire 2022-01-04 Expereo Appoints Ben Elms as Chief Revenue Officer
TeleTrader 2021-02-12 Vodafone Germany removes CGTN from cable
TeleTrader 2020-11-16 Europe opens higher with COVID-19 in focus